AQP4 and multiple sclerosis: AQP4 antibodies (AQP4-abs) have been identified as key differentiators between NMOSD and other CNS demyelinating conditions, such as multiple sclerosis (Wingerchuk et al., 2007; Jasiak-Zatonska et al., 2016).